# CytomX Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cytomx-therapeutics

- Industry: Biotechnology
- Headquarters: San Francisco, US
- Website: www.cytomx.com
- Total disclosed funding: $130M
- Latest round: Series D (Jun 12, 2015)
- Investors on record: 13

## About

Based in California, US, and founded in 2008, CytomX Therapeutics, Inc. is a biopharmaceutical firm focused on oncology that develops antibody medicines based on its pro-body technology platform to treat cancer.

## Funding rounds

- Series D, Jun 12, 2015, $63M — Venrock, Tekla Capital Management, Wellington Management, Fidelity Investments, Redmile Group, Casdin Capital, Deerfield Management, Cormorant Asset Management, Perceptive Advisors
- Series C, Dec 22, 2014, $17M — Canaan Partners, Third Rock Ventures, Roche Venture Fund, Pfizer Venture Investments
- Series B, Jan 31, 2014, $8.4M — Canaan Partners
- Series B, Jul 26, 2012, $13M — Canaan Partners, Third Rock Ventures, Roche Venture Fund
- Series B, Sep 23, 2010, $30M — Third Rock Ventures, Roche Venture Fund

## Investors

- Third Rock Ventures (https://capitalatlas.ai/funds/third-rock-ventures) — Series B, Series C
- Roche Venture Fund (https://capitalatlas.ai/funds/roche-venture-fund) — Series B, Series C
- Canaan Partners (https://capitalatlas.ai/funds/canaan-partners) — Series B, Series C
- Pfizer Venture Investments (https://capitalatlas.ai/funds/pfizer-venture-investments) — Series C
- Venrock (https://capitalatlas.ai/funds/venrock) — Series D
- Tekla Capital Management (https://capitalatlas.ai/funds/tekla-capital-management) — Series D
- Wellington Management (https://capitalatlas.ai/funds/wellington-management) — Series D
- Fidelity Investments (https://capitalatlas.ai/funds/fidelity-investments) — Series D
- Redmile Group (https://capitalatlas.ai/funds/redmile-group) — Series D
- Casdin Capital (https://capitalatlas.ai/funds/casdin-capital) — Series D
- Deerfield Management (https://capitalatlas.ai/funds/deerfield-management) — Series D
- Cormorant Asset Management (https://capitalatlas.ai/funds/cormorant-asset-management) — Series D
- Perceptive Advisors (https://capitalatlas.ai/funds/perceptive-advisors) — Series D